20/20 Biolabs, Inc. (AIDX)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 28
-0.04
-12.1367%
Pre Market
$
+0.04 +13.8132% 0. 31
4.3M Market Cap
- P/E Ratio
- Div Yield
273,254 Volume
- Eps
$ 0.31
Previous Close Want to track AIDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
20/20 Biolabs, Inc. (AIDX) Statistics
Valuation metrics
Market Cap 4.3M
Enterprise value 620.51K
Trailing P/E (ttm) -0.49
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 2.25
Price/Book (mrq) 1.28
Enterprise Value/Revenue 0.3
Enterprise Value/EBITDA -0.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 84.34K
Average volume (90 days) 74.12K
Price summary
52-Week low 0.27
52-Week high 50
Beta -
50-Day moving average 0.49
200-Day moving average 1.05
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.85%
Operating margin -2.16%
Operational effectiveness
Return on assets -0.95%
Return on equity -3.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.42
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 1.99%
Book value per share (mrq) 0.29
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
